MicroPort NeuroScientific Corporation will convene its 2026 annual general meeting on 3 June 2026 at 10:00 a.m. in Shanghai. Shareholders will vote on seven ordinary resolutions that cover dividend distribution, board composition, auditor re-appointment and refreshed share authorities.
Key agenda items
1. Financial statements and dividend • Shareholders are asked to receive the audited consolidated results for the year ended 31 December 2025. • The board proposes a final dividend of HK$0.09 per share, to be offered through a scrip dividend scheme that allows investors to elect new fully paid shares in lieu of cash.
2. Board composition and remuneration • Re-election of six directors: non-executives Dr. Zhang Jie, Mr. Liu Xudong and Ms. Wu Xia; executive director Mr. Xie Zhiyong; and independent non-executive director Mr. Liu Thomas A. • The board will be authorised to determine directors’ remuneration.
3. Auditor appointment • KPMG and KPMG Huazhen LLP are nominated for re-appointment as joint auditors, with their fees to be set by the board.
4. Share capital mandates • A 10 % share repurchase mandate (excluding treasury shares). • A 20 % general issuance mandate that also permits the sale or transfer of treasury shares. • An Extension Mandate allowing the issuance limit to be increased by the number of shares repurchased under the 10 % authority.
Proxy and voting arrangements
• Shareholders may appoint one or more proxies; completed proxy forms must reach Computershare Hong Kong Investor Services no later than 10:00 a.m. on 1 June 2026. • Holders of treasury shares have no voting rights.
The resolutions, if approved, will position MicroPort Neuro for continued capital-management flexibility while maintaining shareholder returns through a scrip dividend option.
Comments